Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang(Central South University), Zhaojian Gong(Central South University), Le Tang(Central South University), Qijia Yan(Ministry of Health), Qianjin Liao(Central South University), Xiangying Deng(Central South University), Guili Ge(Central South University), Can Guo(Central South University), Lvyuan Li(Central South University), Bo Xiang(Central South University), Zhaoyang Zeng(Gansu University of Traditional Chinese Medicine), Ming Zhou(Central South University), Yongzhen Mo(Central South University), Shanshan Zhang(Central South University), Wei Xiong(Central South University), Lei Shi(Nagoya University), Pan Wu(Central South University), Fuyan Wang(W. L. Gore & Associates (Germany)), Xiayu Li(Third Xiangya Hospital), Xianjie Jiang(Central South University), Yijie Zhang(Central South University), Sicheng Zuo(Central South University)
Cited by 123
Related Papers
The cancer metabolic reprogramming and immune response
|Molecular Cancer|2021|1.3k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|713
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
|Journal of Biological Chemistry|2010|429